Head-to-head trial shows Eli Lilly’s oral GLP-1 orforglipron outperforms oral semaglutide

www.scientificamerican.com

Head-to-head trial shows Eli Lilly’s oral GLP-1 orforglipron outperforms oral semaglutide

www.scientificamerican.com

paywallMB to Scientific AmericanEnglish · 15 days ago

Head-to-head trial pitting Eli Lilly’s oral GLP-1 against oral semaglutide underscores efficacy of weight-loss pills

www.scientificamerican.com

A new trial found that Eli Lilly’s GLP-1 pill resulted in greater reductions in blood sugar levels and weight than oral semaglutide did, but fewer people stayed on it

From Scientific American via this RSS feed

You must log in or # to comment.

Chat

Scientific American

scientificamerican

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !scientificamerican@ibbit.at

Community locked: only moderators can create posts. You can still comment on posts.

Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

11 users / day
67 users / week
174 users / month
524 users / 6 months
1 local subscriber
30 subscribers
1.31K Posts
143 Comments
Modlog